This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Aug;11(8):441.

doi: 10.1038/nrclinonc.2014.119. Epub 2014 Jul 15.

Pancreatic cancer: CONKO conquers

M Teresa Villanueva

PMID: 25027593
DOI: 10.1038/nrclinonc.2014.119

Comment

Pancreatic cancer: CONKO conquers

M Teresa Villanueva. Nat Rev Clin Oncol. 2014 Aug.

. 2014 Aug;11(8):441.

doi: 10.1038/nrclinonc.2014.119. Epub 2014 Jul 15.

Author

M Teresa Villanueva

PMID: 25027593
DOI: 10.1038/nrclinonc.2014.119

No abstract available

PubMed Disclaimer

Comment on

Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial.
Oettle H, Riess H, Stieler JM, Heil G, Schwaner I, Seraphin J, Görner M, Mölle M, Greten TF, Lakner V, Bischoff S, Sinn M, Dörken B, Pelzer U. Oettle H, et al. J Clin Oncol. 2014 Aug 10;32(23):2423-9. doi: 10.1200/JCO.2013.53.6995. Epub 2014 Jun 30. J Clin Oncol. 2014. PMID: 24982456 Clinical Trial.

References

1. J Clin Oncol. 2014 Aug 10;32(23):2423-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information